Reovirus oncolysis of human breast cancer

Human Gene Therapy

Volumn 13, Issue 5, 2002, Pages 641-652

  Norman, Kara L ^a   Coffey, Matthew C ^a   Hirasawa, Kensuke ^a   Demetrick, Douglas J ^a,b   Nishikawa, Sandra G ^a   DiFrancesco, Lisa M ^a,b   Strong, James E ^a   Lee, Patrick W K ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b CALGARY LABORATORY SERVICES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER CELL; CANCER REGRESSION; CONTROLLED STUDY; CYTOLYSIS; DRUG DISTRIBUTION; FEASIBILITY STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; INFECTION RESISTANCE; INJECTION SITE; MOUSE; NONHUMAN; ONCOGENE RAS; REOVIRUS; RNA VIRUS INFECTION; SCID MOUSE; SIGNAL TRANSDUCTION; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; BIOLOGICAL THERAPY; BREAST NEOPLASMS; CELL DEATH; FEMALE; GENE THERAPY; GENES, RAS; HUMANS; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; REOVIRIDAE; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; VIRUS REPLICATION;

ANIMALIA; REOVIRUS SP.; RNA VIRUSES;

EID: 0036210203     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340252837233     Document Type: Article

References (47)

1. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes
2. Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer
3. A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway
4. Identification of protein-tyrosine phosphatase 1B as the major tyrosine phosphatase activity capable of dephosphorylating and activating c-Src in several human breast cancer cell lines
5. Humanization of an anti-p185HER2 antibody for human cancer therapy
6. Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
7. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease
8. Reovirus therapy of tumors with activated Ras pathway
9. Distinct tyrosine autophosphorylatio n sites negatively and positively modulate Neu-mediated transformation
10. Activation of Src in human breast tumor cell lines: Elevated levels of phosphotyrosine phosphatase activity that preferentially recognizes the Src carboxy terminal negative regulatory tyrosine 530
11. Anti-epidermal growth factor receptor antibodies inhibit the autocrine-stimulated growth of MDA-468 human breast cancer cells
12. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas
13. Expression of pp60c-src protein kinase in adult and fetal human tissue: High activities in some sarcomas and mammary carcinomas
14. Activation of the Ras signaling pathway in human breast cancer cells overexpressing erbB-2
15. Epidermal growth factor receptor-negative tumors are predominantly confined to the subgroup of estradiol receptor-positive human primary breast cancers
16. A position 12-activated H-ras oncogene in all HS578T mammary carci-nosarcoma cells but not normal mammary cells of the same patient
17. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
18. Characterization of anti-reovirus immunoglobulins secreted by cloned hybridoma cell lines
19. v-src signaling in breast cancer cells
20. Epithelial component of host-tumor interactions in the orthotopic site preference of a mouse mammary tumor
21. Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity
22. Metastasis from human breast cancer cell lines
23. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice
24. Elevated activity and expression of Src-family kinases in human breast carcinoma tissue versus matched nontumor tissue
25. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer
26. Incidence of activating ras oncogene mutations associated with primary and metastatic human breast cancer
27. Analysis of pp60c-src protein kinase activity in human tumor cell lines and tissues
28. The HER-2/neu oncogene in breast cancer: Prognostic factor, predictive factor, and target for therapy
29. Growth and metastasis of surgical specimens of human breast carcinomas in SCID mice
30. Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines
31. Intracellular coexpression of epidermal growth factor receptor, Her-2/neu, and p21ras in human breast cancers: Evidence for the existence of distinctive patterns of genetic evolution that are common to tumors from different patients
32. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice
33. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
34. Polypep-tide components of virons, top component and cores of reovirus type 3
35. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10
36. The v-erbB oncogene confers enhanced cellular susceptibility to reovirus infection
37. Evidence that the epidermal growth factor receptor on host cells confers reovirus infection efficiency
38. The molecular basis of viral oncolysis: Usurpation of the Ras signaling pathway by reovirus
39. Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas
40. The E3-11.6-kDa adenovirus death protein (ADP) is required for efficient cell death: Characterisation of cells infected with adp mutants
41. Phase Ia/Ib trial of bi-specific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu
42. c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis
43. The mitogenic signaling pathway for fibroblast growth factor-2 involves the tyrosine phosphorylation of cyclin D2 in MCF-7 human breast cancer cells
44. Growth characteristics and metastatic properties of human breast cancer xenografts in immunodeficient mice
45. Induction of mammary epithelial hyperplasias and mammary tumors in transgenic mice expressing a murine mammary tumor virus/activated c-src fusion gene
46. Reovirus as an oncolytic agent against experimental human malignant gliomas
47. Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms